Search

Your search keyword '"Peres, Lauren C."' showing total 334 results
Start Over Author "Peres, Lauren C."
334 results on '"Peres, Lauren C."'

1. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Author

Afrough, Aimaz, Hashmi, Hamza, Hansen, Doris K., Sidana, Surbhi, Ahn, Chul, Peres, Lauren C., Dima, Danai, Freeman, Ciara L., Puglianini, Omar Castaneda, Kocoglu, Mehmet H., Atrash, Shebli, Voorhees, Peter M., Shune, Leyla, McGuirk, Joseph P., Simmons, Gary, Sborov, Douglas W., Davis, James A., Kaur, Gurbakhash, Sannareddy, Aishwarya, Ferreri, Christopher J., Gaballa, Mahmoud R., Goldsmith, Scott, Nadeem, Omar, Midha, Shonali, Wagner, Charlotte B., Locke, Frederick L., Patel, Krina K., Khouri, Jack, Anderson, Jr., Larry D., and Lin, Yi

Published
2024
Full Text
View/download PDF

2. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium

Author

Petrick, Jessica L., Joslin, Charlotte E., Johnson, Courtney E., Camacho, T. Fabian, Peres, Lauren C., Bandera, Elisa V., Barnard, Mollie E., Beeghly, Alicia, Bethea, Traci N., Dempsey, Lauren F., Guertin, Kristin, Harris, Holly R., Moorman, Patricia G., Myers, Evan R., Ochs-Balcom, Heather M., Rosenow, Will, Setiawan, V. Wendy, Wu, Anna H., Schildkraut, Joellen M., and Rosenberg, Lynn

Published
2023
Full Text
View/download PDF

3. Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women

Author

Johnson, Courtney E., Alberg, Anthony J., Bandera, Elisa V., Peres, Lauren C., Akonde, Maxwell, Collin, Lindsay J., Cote, Michele L., Hastert, Theresa A., Hébert, James R., Peters, Edward S., Qin, Bonnie, Terry, Paul, Schwartz, Ann G., Bondy, Melissa, Epstein, Michael P., Mandle, Hannah B., Marks, Jeffrey R., Lawson, Andrew B., and Schildkraut, Joellen M.

Published
2023
Full Text
View/download PDF

4. Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Author

Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Jr., Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., and Castaneda Puglianini, Omar Alexis

Published
2023
Full Text
View/download PDF

5. Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy

Author

Peres, Lauren C., Oswald, Laura B., Dillard, Christen M., De Avila, Gabriel, Nishihori, Taiga, Blue, Brandon J., Freeman, Ciara L., Locke, Frederick L., Alsina, Melissa, Castaneda Puglianini, Omar, Shune, Leyla, Sborov, Douglas W., Wagner, Charlotte, Dima, Danai, Hashmi, Hamza, Davis, James A., Kocoglu, Mehmet H., Badros, Ashraf Z., Atrash, Shebli, Simmons, Gary, Kalariya, Nilesh, Ferreri, Christopher, Anderson, Larry D., Jr, Afrough, Aimaz, Kaur, Gurbakhash, Lin, Yi, Liu, Lawrence, Nadeem, Omar, Voorhees, Peter, Khouri, Jack, McGuirk, Joseph, Sidana, Surbhi, Hansen, Doris K., and Patel, Krina

Published
2024
Full Text
View/download PDF

6. Role of neighborhood context in ovarian cancer survival disparities: current research and future directions

Author

Gomez, Scarlett L., Chirikova, Ekaterina, McGuire, Valerie, Collin, Lindsay J., Dempsey, Lauren, Inamdar, Pushkar P., Lawson-Michod, Katherine, Peters, Edward S., Kushi, Lawrence H., Kavecansky, Juraj, Shariff-Marco, Salma, Peres, Lauren C., Terry, Paul, Bandera, Elisa V., Schildkraut, Joellen M., Doherty, Jennifer A., and Lawson, Andrew

Published
2023
Full Text
View/download PDF

7. Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma

Author

Lee, Dae Hyun, Kumar, Abhishek, Mohammed, Turab, Peres, Lauren C., Alsina, Melissa, Bachmeier, Christina, Blue, Brandon J., Brayer, Jason, Chandrasekhar, Sanjay, Grajales Cruz, Ariel, De Avila, Gabe, Elmariah, Hany, Faramand, Rawan, Freeman, Ciara, Jain, Michael, Khadka, Sushmita, Khimani, Farhad, Liu, Hien, Nishihori, Taiga, Oswald, Laura B., Castaneda Puglianini, Omar A., Shain, Kenneth H., Smith, Eric, Baz, Rachid C., Locke, Frederick L., Oliveira, Guilherme H., Alomar, Mohammed, and Hansen, Doris K.

Published
2023
Full Text
View/download PDF

8. Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium

Author

Ochs-Balcom, Heather M., Johnson, Courtney, Guertin, Kristin A., Qin, Bo, Beeghly-Fadiel, Alicia, Camacho, Fabian, Bethea, Traci N., Dempsey, Lauren F., Rosenow, Will, Joslin, Charlotte E., Myers, Evan, Moorman, Patricia G., Harris, Holly R., Peres, Lauren C., Wendy Setiawan, V., Wu, Anna H., Rosenberg, Lynn, Schildkraut, Joellen M., and Bandera, Elisa V.

Published
2022
Full Text
View/download PDF

9. Identification of novel epithelial ovarian cancer loci in women of African ancestry

Author

Manichaikul, Ani, Peres, Lauren C, Wang, Xin‐Qun, Barnard, Mollie E, Chyn, Deanna, Sheng, Xin, Du, Zhaohui, Tyrer, Jonathan, Dennis, Joseph, Schwartz, Ann G, Cote, Michele L, Peters, Edward, Moorman, Patricia G, Bondy, Melissa, Barnholtz‐Sloan, Jill S, Terry, Paul, Alberg, Anthony J, Bandera, Elisa V, Funkhouser, Ellen, Wu, Anna H, Pearce, Celeste Leigh, Pike, Malcom, Setiawan, Veronica Wendy, Haiman, Christopher A, Consortium, the African American Breast Cancer, Consortium, the African Ancestry Prostate Cancer, Palmer, Julie R, LeMarchand, Loic, Wilkens, Lynne R, Berchuck, Andrew, Doherty, Jennifer A, Modugno, Francesmary, Ness, Roberta, Moysich, Kirsten, Karlan, Beth Y, Whittemore, Alice S, McGuire, Valerie, Sieh, Weiva, Lawrenson, Kate, Gayther, Simon, Sellers, Thomas A, Pharoah, Paul, Schildkraut, Joellen M, and Consortium, the African American Cancer Epidemiology Study and the Ovarian Cancer Association

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Cancer, Prevention, Ovarian Cancer, Rare Diseases, Genetics, Clinical Research, 2.1 Biological and endogenous factors, Aetiology, Black or African American, Aldo-Keto Reductase Family 1 Member C3, Antigens, Neoplasm, Black People, Breast Neoplasms, Carcinoma, Ovarian Epithelial, Female, Follistatin, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Neoplasm Proteins, Polymorphism, Single Nucleotide, United States, White People, ovarian cancer, African ancestry, genome wide association study, gene expression, eQTLs, African American Breast Cancer Consortium, African Ancestry Prostate Cancer Consortium, African American Cancer Epidemiology Study (AACES) and the Ovarian Cancer Association Consortium, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

Women of African ancestry have lower incidence of epithelial ovarian cancer (EOC) yet worse survival compared to women of European ancestry. We conducted a genome-wide association study in African ancestry women with 755 EOC cases, including 537 high-grade serous ovarian carcinomas (HGSOC) and 1,235 controls. We identified four novel loci with suggestive evidence of association with EOC (p

Published
2020

10. Predictors of survival trajectories among women with epithelial ovarian cancer

Author

Peres, Lauren C, Sinha, Sweta, Townsend, Mary K, Fridley, Brooke L, Karlan, Beth Y, Lutgendorf, Susan K, Shinn, Eileen, Sood, Anil K, and Tworoger, Shelley S

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Clinical Research, Ovarian Cancer, Prevention, Cancer, 2.4 Surveillance and distribution, Aetiology, Good Health and Well Being, Aged, Black People, Carcinoma, Ovarian Epithelial, Female, Humans, Middle Aged, Native Hawaiian or Other Pacific Islander, Neoplasm Staging, Ovarian Neoplasms, Prognosis, SEER Program, United States, White People, Ovarian cancer, Long-term survivors, Mortality, Histotype, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis, Reproductive medicine
Abstract

ObjectiveAlthough ovarian cancer is a deadly disease, approximately a third of women survive ≥9 years after diagnosis. The factors associated with achieving long-term survival are not well understood. In this study, data from the Surveillance, Epidemiology, and End Results (SEER) program were used to determine predictors of survival trajectories among women with epithelial ovarian cancer and across histotype (high-grade serous carcinoma (HGSC) and non-HGSC).MethodsData on 35,868 women diagnosed with epithelial ovarian cancer in 2004-2016 were extracted from SEER. Extended Cox proportional hazards regression was used to estimate overall and histotype-specific associations between patient and tumor characteristics and all-cause mortality within each survival time (t) interval (t 70 years at diagnosis, where a high risk of mortality was observed in both the t

Published
2020

11. The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality

Author

Davis, Evan W, primary, Attwood, Kristopher, additional, Prunier, Joseph, additional, Paragh, Gyorgy, additional, Joseph, Janine M, additional, Klein, André, additional, Roche, Charles, additional, Barone, Nancy, additional, Etter, John Lewis, additional, Ray, Andrew D, additional, Trabert, Britton, additional, Schabath, Matthew B, additional, Peres, Lauren C, additional, and Cannioto, Rikki, additional

Published
2024
Full Text
View/download PDF

12. Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms

Author

Davidson, Natalie R., primary, Barnard, Mollie E., additional, Hippen, Ariel A., additional, Campbell, Amy, additional, Johnson, Courtney E., additional, Way, Gregory P., additional, Dalley, Brian K., additional, Berchuck, Andrew, additional, Salas, Lucas A., additional, Peres, Lauren C., additional, Marks, Jeffrey R., additional, Schildkraut, Joellen M., additional, Greene, Casey S., additional, and Doherty, Jennifer A., additional

Published
2024
Full Text
View/download PDF

13. Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium

Author

Meagher, Nicola S, primary, White, Kami K, additional, Wilkens, Lynne R, additional, Bandera, Elisa V, additional, Berchuck, Andrew, additional, Carney, Michael E, additional, Cramer, Daniel W, additional, Cushing-Haugen, Kara L, additional, Jordan, Susan, additional, Kaufmann, Scott H, additional, Le, Nhu D, additional, Pike, Malcolm C, additional, Riggan, Marjorie, additional, Qin, Bo, additional, Rothstein, Joseph H, additional, Titus, Linda, additional, Winham, Stacey J, additional, Anton-Culver, Hoda, additional, Doherty, Jennifer A, additional, Goode, Ellen L, additional, Pearce, Celeste Leigh, additional, Risch, Harvey A, additional, AOCS Group, on behalf of the, additional, Webb, Penelope M, additional, Cook, Linda S, additional, Goodman, Marc T, additional, Harris, Holly R, additional, Le Marchand, Loic, additional, McGuire, Valerie, additional, Pharoah, Paul D P, additional, Sarink, Danja, additional, Schildkraut, Joellen M, additional, Sieh, Weiva, additional, Terry, Kathryn L, additional, Thompson, Pamela J, additional, Whittemore, Alice S, additional, Wu, Anna H, additional, Peres, Lauren C, additional, and Merritt, Melissa A, additional

Published
2024
Full Text
View/download PDF

14. Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Author

Logue, Jennifer M., Peres, Lauren C., Hashmi, Hamza, Colin-Leitzinger, Christelle M., Shrewsbury, Alexandria M., Hosoya, Hitomi, Gonzalez, Rebecca M., Copponex, Christina, Kottra, Krista H., Hovanky, Vanna, Sahaf, Bita, Patil, Sunita, Lazaryan, Aleksandr, Jain, Michael D., Baluch, Aliyah, Klinkova, Olga V., Bejanyan, Nelli, Faramand, Rawan G., Elmariah, Hany, Khimani, Farhad, Davila, Marco L., Mishra, Asmita, Blue, Brandon J., Grajales-Cruz, Ariel F., Castaneda Puglianini, Omar A., Liu, Hien D., Nishihori, Taiga, Freeman, Ciara L., Brayer, Jason B., Shain, Kenneth H., Baz, Rachid C., Locke, Frederick L., Alsina, Melissa, Sidana, Surbhi, and Hansen, Doris K.

Published
2022
Full Text
View/download PDF

15. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

Author

Grant, Delores J, Manichaikul, Ani, Alberg, Anthony J, Bandera, Elisa V, Barnholtz‐Sloan, Jill, Bondy, Melissa, Cote, Michele L, Funkhouser, Ellen, Moorman, Patricia G, Peres, Lauren C, Peters, Edward S, Schwartz, Ann G, Terry, Paul D, Wang, Xin‐Qun, Keku, Temitope O, Hoyo, Cathrine, Berchuck, Andrew, Sandler, Dale P, Taylor, Jack A, O’Brien, Katie M, Edwards, Digna R Velez, Edwards, Todd L, Beeghly‐Fadiel, Alicia, Wentzensen, Nicolas, Pearce, Celeste Leigh, Wu, Anna H, Whittemore, Alice S, McGuire, Valerie, Sieh, Weiva, Rothstein, Joseph H, Modugno, Francesmary, Ness, Roberta, Moysich, Kirsten, Rossing, Mary Anne, Doherty, Jennifer A, Sellers, Thomas A, Permuth‐Way, Jennifer B, Monteiro, Alvaro N, Levine, Douglas A, Setiawan, Veronica Wendy, Haiman, Christopher A, LeMarchand, Loic, Wilkens, Lynne R, Karlan, Beth Y, Menon, Usha, Ramus, Susan, Gayther, Simon, Gentry‐Maharaj, Aleksandra, Terry, Kathryn L, Cramer, Daniel W, Goode, Ellen L, Larson, Melissa C, Kaufmann, Scott H, Cannioto, Rikki, Odunsi, Kunle, Etter, John L, Huang, Ruea‐Yea, Bernardini, Marcus Q, Tone, Alicia A, May, Taymaa, Goodman, Marc T, Thompson, Pamela J, Carney, Michael E, Tworoger, Shelley S, Poole, Elizabeth M, Lambrechts, Diether, Vergote, Ignace, Vanderstichele, Adriaan, Van Nieuwenhuysen, Els, Anton‐Culver, Hoda, Ziogas, Argyrios, Brenton, James D, Bjorge, Line, Salvensen, Helga B, Kiemeney, Lambertus A, Massuger, Leon FAG, Pejovic, Tanja, Bruegl, Amanda, Moffitt, Melissa, Cook, Linda, Le, Nhu D, Brooks‐Wilson, Angela, Kelemen, Linda E, Pharoah, Paul DP, Song, Honglin, Campbell, Ian, Eccles, Diana, DeFazio, Anna, Kennedy, Catherine J, and Schildkraut, Joellen M

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Nutrition, Rare Diseases, Clinical Research, Genetics, Ovarian Cancer, Prevention, Cancer, 2.1 Biological and endogenous factors, Aetiology, Black or African American, Bayes Theorem, Carcinoma, Ovarian Epithelial, ErbB Receptors, Female, Genetic Association Studies, Glucuronosyltransferase, Humans, Logistic Models, Middle Aged, Neoplasm Grading, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Receptors, Calcitriol, Vitamin D, African ancestry risk, genetic association, ovarian cancer, vitamin D pathway, Biochemistry and Cell Biology, Oncology and carcinogenesis
Abstract

An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom-designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high-grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significance of selected SNPs using the Bayesian False Discovery Probability (BFDP). A significant association with EOC was identified in the UGT2A1/2 region for the SNP rs10017134 (per allele OR = 1.4, 95% CI = 1.2-1.7, P = 1.2 × 10-6 , BFDP = 0.02); and an association with HGSOC was identified in the EGFR region for the SNP rs114972508 (per allele OR = 2.3, 95% CI = 1.6-3.4, P = 1.6 × 10-5 , BFDP = 0.29) and in the UGT2A1/2 region again for rs1017134 (per allele OR = 1.4, 95% CI = 1.2-1.7, P = 2.3 × 10-5 , BFDP = 0.23). Genetic variants in the EGFR and UGT2A1/2 may increase susceptibility of EOC in AA women. Future studies to validate these findings are warranted. Alterations in EGFR and UGT2A1/2 could perturb enzyme efficacy, proliferation in ovaries, impact and mark susceptibility to EOC.

Published
2019

16. Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma

Author

Peres, Lauren C., Colin-Leitzinger, Christelle M., Teng, Mingxiang, Dutil, Julie, Alugubelli, Raghunandan R., DeAvila, Gabriel, Teer, Jamie K., Du, Dongliang, Mo, Qianxing, Siegel, Erin M., Hampton, Oliver A., Alsina, Melissa, Brayer, Jason, Blue, Brandon, Baz, Rachid, Silva, Ariosto S., Nishihori, Taiga, Shain, Kenneth H., and Gillis, Nancy

Published
2022
Full Text
View/download PDF

17. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Author

Peres, Lauren C, Risch, Harvey, Terry, Kathryn L, Webb, Penelope M, Goodman, Marc T, Wu, Anna H, Alberg, Anthony J, Bandera, Elisa V, Barnholtz-Sloan, Jill, Bondy, Melissa L, Cote, Michele L, Funkhouser, Ellen, Moorman, Patricia G, Peters, Edward S, Schwartz, Ann G, Terry, Paul D, Manichaikul, Ani, Abbott, Sarah E, Camacho, Fabian, Jordan, Susan J, Nagle, Christina M, Australian Ovarian Cancer Study Group, Anne Rossing, Mary, Doherty, Jennifer A, Modugno, Francesmary, Moysich, Kirsten, Ness, Roberta, Berchuck, Andrew, Cook, Linda, Le, Nhu, Brooks-Wilson, Angela, Sieh, Weiva, Whittemore, Alice, McGuire, Valerie, Rothstein, Joseph, Anton-Culver, Hoda, Ziogas, Argyrios, Pearce, Celeste L, Tseng, Chiuchen, Pike, Malcom, Schildkraut, Joellen M, and African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium

Subjects
Australian Ovarian Cancer Study Group, African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium, Statistics, Public Health and Health Services, Epidemiology
Published
2018

18. Abstract B037: Physical inactivity is associated with ovarian cancer in women of African ancestry

Author

Minlikeeva, Albina, primary, Lima, Sarah M., additional, Johnson, Courtney, additional, Bandera, Elisa V., additional, Beeghly-Fadiel, Alicia, additional, Bethea, Traci N., additional, Petrick, Jessica, additional, Joslin, Charlotte E., additional, Myers, Evan, additional, Harris, Holly R., additional, Peres, Lauren C., additional, Setiawan, V. Wendy, additional, Wu, Anna H., additional, Rosenberg, Lynn, additional, Schildkraut, Joellen M., additional, and Ochs-Balcom, Heather M., additional

Published
2024
Full Text
View/download PDF

21. WITHDRAWN: Impact of spatial clustering of cytotoxic and tumor infiltrating lymphocytes on overall survival in women with high grade serous ovarian cancer

Author

Soupir, Alex C., primary, Townsend, Mary K., additional, Hathaway, Cassandra A., additional, Nguyen, Jonathan, additional, Moran Segura, Carlos, additional, Saeed-Vafa, Daryoush, additional, Ospina, Oscar E., additional, Peres, Lauren C., additional, Conejo-Garcia, Jose R., additional, Terry, Kathryn L., additional, Tworoger, Shelley S., additional, and Fridley, Brooke L., additional

Published
2024
Full Text
View/download PDF

22. Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.

Author

Nepomuceno, Thales C., Lyra, Paulo, Zhu, Jianbin, Yi, Fanchao, Martin, Rachael H., Lupu, Daniel, Peterson, Luke, Peres, Lauren C., Berry, Anna, Iversen, Edwin S., Couch, Fergus J., Mo, Qianxing, and Monteiro, Alvaro N.

Subjects
BIG data, BRCA genes, BREAST cancer, CANCER patients, CANCER genetics, DATA entry, SELECTION bias (Statistics), MEDICAL record databases, MEDICAL registries
Abstract

PURPOSE: The emergence of large real-world clinical databases and tools to mine electronic medical records has allowed for an unprecedented look at large data sets with clinical and epidemiologic correlates. In clinical cancer genetics, real-world databases allow for the investigation of prevalence and effectiveness of prevention strategies and targeted treatments and for the identification of barriers to better outcomes. However, real-world data sets have inherent biases and problems (eg, selection bias, incomplete data, measurement error) that may hamper adequate analysis and affect statistical power. METHODS: Here, we leverage a real-world clinical data set from a large health network for patients with breast cancer tested for variants in BRCA1 and BRCA2 (N = 12,423). We conducted data cleaning and harmonization, cross-referenced with publicly available databases, performed variant reassessment and functional assays, and used functional data to inform a variant's clinical significance applying American College of Medical Geneticists and the Association of Molecular Pathology guidelines. RESULTS: In the cohort, White and Black patients were over-represented, whereas non-White Hispanic and Asian patients were under-represented. Incorrect or missing variant designations were the most significant contributor to data loss. While manual curation corrected many incorrect designations, a sizable fraction of patient carriers remained with incorrect or missing variant designations. Despite the large number of patients with clinical significance not reported, original reported clinical significance assessments were accurate. Reassessment of variants in which clinical significance was not reported led to a marked improvement in data quality. CONCLUSION: We identify the most common issues with BRCA1 and BRCA2 testing data entry and suggest approaches to minimize data loss and keep interpretation of clinical significance of variants up to date. We identify the most common issues with testing data entry and suggest approaches to minimize data loss and keep interpretation of clinical significance of variants up to date. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms

Author

Davidson, Natalie R., primary, Barnard, Mollie E., additional, Hippen, Ariel A., additional, Campbell, Amy, additional, Johnson, Courtney E., additional, Way, Gregory P., additional, Dalley, Brian K., additional, Berchuck, Andrew, additional, Salas, Lucas A., additional, Peres, Lauren C., additional, Marks, Jeffrey R., additional, Schildkraut, Joellen M., additional, Greene, Casey S., additional, and Doherty, Jennifer A., additional

Published
2023
Full Text
View/download PDF

25. The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women

Author

Lawson, Andrew B., primary, Kim, Joanne, additional, Johnson, Courtney, additional, Ratnapradipa, Kendra L., additional, Alberg, Anthony J., additional, Akonde, Maxwell, additional, Hastert, Theresa, additional, Bandera, Elisa V., additional, Terry, Paul, additional, Mandle, Hannah, additional, Cote, Michele L., additional, Bondy, Melissa, additional, Marks, Jeffrey, additional, Peres, Lauren C., additional, Schildkraut, Joellen, additional, and Peters, Edward S., additional

Published
2023
Full Text
View/download PDF

26. Ovarian Cancer in Women of African Ancestry (OCWAA) consortium : a resource of harmonized data from eight epidemiologic studies of African American and white women

Author

Schildkraut, Joellen M., Peres, Lauren C., Bethea, Traci N., Camacho, Fabian, Chyn, Deanna, Cloyd, Emily K., Bandera, Elisa V., Beeghly-Fadiel, Alicia, Lipworth, Loren, Joslin, Charlotte E., Davis, Faith G., Moorman, Patricia G., Myers, Evan, Ochs-Balcom, Heather M., Setiawan, Veronica Wendy, Pike, Malcolm C., Wu, Anna H., and Rosenberg, Lynn

Published
2019

28. Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

Author

Oswald, Laura B., primary, Gudenkauf, Lisa M., additional, Li, Xiaoyin, additional, De Avila, Gabriel, additional, Peres, Lauren C., additional, Kirtane, Kedar, additional, Gonzalez, Brian D., additional, Hoogland, Aasha I., additional, Nguyen, Oanh, additional, Rodriguez, Yvelise, additional, Baz, Rachid C., additional, Shain, Kenneth H., additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Freeman, Ciara, additional, Castaneda Puglianini, Omar, additional, Nishihori, Taiga, additional, Liu, Hien, additional, Blue, Brandon, additional, Grajales-Cruz, Ariel, additional, Jim, Heather S. L., additional, and Hansen, Doris K., additional

Published
2023
Full Text
View/download PDF

31. Tubal ligation and ovarian cancer risk in African American women

Author

McNamara, Chrissy, Abbott, Sarah E., Bandera, Elisa V., Qin, Bo, Peres, Lauren C., Camacho, Fabian, Moorman, Patricia G., Alberg, Anthony J., Barnholtz-Sloan, Jill S., Bondy, Melissa, Cote, Michele L., Funkhouser, Ellen, Peters, Edward S., Schwartz, Ann G., Schildkraut, Joellen M., and Terry, Paul

Published
2017

36. Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer

Author

Harris, Holly R., primary, Peres, Lauren C., additional, Johnson, Courtney E., additional, Guertin, Kristin A., additional, Beeghly, Alicia, additional, Bandera, Elisa V., additional, Bethea, Traci N., additional, Joslin, Charlotte E., additional, Wu, Anna H., additional, Moorman, Patricia G., additional, Ochs-Balcom, Heather M., additional, Petrick, Jessica L., additional, Setiawan, Veronica W., additional, Rosenberg, Lynn, additional, Schildkraut, Joellen M., additional, and Myers, Evan, additional

Published
2023
Full Text
View/download PDF

38. Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Author

Hansen, Doris K., primary, Sidana, Surbhi, additional, Peres, Lauren C., additional, Colin Leitzinger, Christelle, additional, Shune, Leyla, additional, Shrewsbury, Alexandria, additional, Gonzalez, Rebecca, additional, Sborov, Douglas W., additional, Wagner, Charlotte, additional, Dima, Danai, additional, Hashmi, Hamza, additional, Kocoglu, Mehmet H., additional, Atrash, Shebli, additional, Simmons, Gary, additional, Kalariya, Nilesh, additional, Ferreri, Christopher, additional, Afrough, Aimaz, additional, Kansagra, Ankit, additional, Voorhees, Peter, additional, Baz, Rachid, additional, Khouri, Jack, additional, Alsina, Melissa, additional, McGuirk, Joseph, additional, Locke, Frederick L., additional, and Patel, Krina K., additional

Published
2023
Full Text
View/download PDF

40. Supplementary Material (Table S1-S3, Figure S1-S2) from High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium

Author

Peres, Lauren C., primary, Mallen, Adrianne R., primary, Townsend, Mary K., primary, Poole, Elizabeth M., primary, Trabert, Britton, primary, Allen, Naomi E., primary, Arslan, Alan A., primary, Dossus, Laure, primary, Fortner, Renée T., primary, Gram, Inger T., primary, Hartge, Patricia, primary, Idahl, Annika, primary, Kaaks, Rudolf, primary, Kvaskoff, Marina, primary, Magliocco, Anthony M., primary, Merritt, Melissa A., primary, Quirós, J. Ramón, primary, Tjonneland, Anne, primary, Trichopoulou, Antonia, primary, Tumino, Rosario, primary, van Gils, Carla H., primary, Visvanathan, Kala, primary, Wentzensen, Nicolas, primary, Zeleniuch-Jacquotte, Anne, primary, and Tworoger, Shelley S., primary

Published
2023
Full Text
View/download PDF

41. Data from High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium

Author

Peres, Lauren C., primary, Mallen, Adrianne R., primary, Townsend, Mary K., primary, Poole, Elizabeth M., primary, Trabert, Britton, primary, Allen, Naomi E., primary, Arslan, Alan A., primary, Dossus, Laure, primary, Fortner, Renée T., primary, Gram, Inger T., primary, Hartge, Patricia, primary, Idahl, Annika, primary, Kaaks, Rudolf, primary, Kvaskoff, Marina, primary, Magliocco, Anthony M., primary, Merritt, Melissa A., primary, Quirós, J. Ramón, primary, Tjonneland, Anne, primary, Trichopoulou, Antonia, primary, Tumino, Rosario, primary, van Gils, Carla H., primary, Visvanathan, Kala, primary, Wentzensen, Nicolas, primary, Zeleniuch-Jacquotte, Anne, primary, and Tworoger, Shelley S., primary

Published
2023
Full Text
View/download PDF

43. Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES)

Author

Mills, Anne M., Peres, Lauren C., Meiss, Alice, Ring, Kari L., Modesitt, Susan C., Abbott, Sarah E., Alberg, Anthony J., Bandera, Elisa V., Barnholtz-Sloan, Jill, Bondy, Melissa L., Cote, Michele L., Funkhouser, Ellen, Moorman, Patricia G., Peters, Edward S., Schwartz, Ann G., Terry, Paul D., Wallace, Kristin, and Schildkraut, Joellen M.

Published
2019
Full Text
View/download PDF

44. Associations between Patient-Reported Outcomes and 90-Day Response to Chimeric Antigen Receptor T-Cell Therapy: A Bayesian Network Analysis

Author

Oswald, Laura B., primary, Luo, Yi, additional, Li, Xiaoyin, additional, Hoogland, Aasha I., additional, Gonzalez, Brian D., additional, Hansen, Doris K., additional, Jain, Michael D., additional, Locke, Frederick L., additional, Peres, Lauren C., additional, Kirtane, Kedar, additional, El Naqa, Issam, additional, and Jim, Heather S.L., additional

Published
2022
Full Text
View/download PDF

45. Patterns of Relapse and Clinical Outcomes in Multiple Myeloma Patients after Anti-BCMA CAR T-Cell Therapy: Implications for Patient's Monitoring after CAR T-Cell Therapy

Author

Castaneda Puglianini, Omar Alexis, primary, Peres, Lauren C., additional, Hansen, Doris K., additional, Nishihori, Taiga, additional, Grajales-Cruz, Ariel F, additional, Blue, Brandon J., additional, Brayer, Jason, additional, Freeman, Ciara L., additional, Shain, Kenneth H., additional, Liu, Hien D., additional, Ochoa, Jose, additional, Locke, Frederick L., additional, Baz, Rachid C., additional, and Alsina, Melissa, additional

Published
2022
Full Text
View/download PDF

46. Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received a Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience

Author

Ferreri, Christopher J., primary, Hildebrandt, Michelle A.T., additional, Hashmi, Hamza, additional, Shune, Leyla O., additional, McGuirk, Joseph P., additional, Sborov, Douglas W., additional, Wagner, Charlotte B, additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Voorhees, Peter M., additional, Khouri, Jack, additional, Dima, Danai, additional, Afrough, Aimaz, additional, Sannareddy, Aishwarya, additional, Simmons, Gary, additional, Davis, James, additional, Kalariya, Nilesh, additional, Peres, Lauren C., additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Sidana, Surbhi, additional, Hansen, Doris K., additional, Patel, Krina, additional, and Castaneda Puglianini, Omar Alexis, additional

Published
2022
Full Text
View/download PDF

47. Factors Associated with Refractoriness or Early Progression after Idecabtagene Vicleucel (Ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): U.S. Myeloma CAR T Consortium Real World Experience

Author

Hashmi, Hamza, primary, Hansen, Doris K., additional, Peres, Lauren C., additional, Castaneda Puglianini, Omar Alexis, additional, Freeman, Ciara L., additional, De Avila, Gabriel, additional, Sidana, Surbhi, additional, Shune, Leyla O., additional, Sborov, Douglas W., additional, Davis, James, additional, Wagner, Charlotte B., additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Voorhees, Peter M., additional, Simmons, Gary, additional, Ferreri, Christopher J., additional, Kalariya, Nilesh, additional, Sannareddy, Aishwarya, additional, Dima, Danai, additional, Khouri, Jack, additional, McGuirk, Joseph P., additional, Locke, Frederick L., additional, Baz, Rachid C., additional, Patel, Krina, additional, and Alsina, Melissa, additional

Published
2022
Full Text
View/download PDF

48. Racial and Ethnic Differences in Clinical Outcomes Among Multiple Myeloma Patients Treated with CAR T Therapy

Author

Peres, Lauren C., primary, Oswald, Laura B., additional, Dillard, Christen, additional, De Avila, Gabriel, additional, Nishihori, Taiga, additional, Blue, Brandon J., additional, Freeman, Ciara L., additional, Locke, Frederick L., additional, Alsina, Melissa, additional, Castaneda Puglianini, Omar Alexis, additional, Shune, Leyla O., additional, Sborov, Douglas W., additional, Wagner, Charlotte B, additional, Dima, Danai, additional, Hashmi, Hamza, additional, Davis, James, additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Simmons, Gary, additional, Kalariya, Nilesh, additional, Ferreri, Christopher J., additional, Sannareddy, Aishwarya, additional, Afrough, Aimaz, additional, Voorhees, Peter M., additional, Khouri, Jack, additional, McGuirk, Joseph P., additional, Sidana, Surbhi, additional, Hansen, Doris K., additional, and Patel, Krina, additional

Published
2022
Full Text
View/download PDF

49. Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The U.S. Myeloma CAR T Consortium Real World Experience

Author

Khouri, Jack, primary, Li, Hong, additional, Hansen, Doris K., additional, Sidana, Surbhi, additional, Shune, Leyla O., additional, DeJarnette, Shaun, additional, Anwer, Faiz, additional, Sborov, Douglas W, additional, Wagner, Charlotte B, additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Voorhees, Peter M., additional, Valent, Jason, additional, Peres, Lauren C., additional, Hovanky, Vanna, additional, Simmons, Gary, additional, Dima, Danai, additional, Kalariya, Nilesh, additional, Afrough, Aimaz, additional, Kaur, Gurbakhash, additional, Sannareddy, Aishwarya, additional, Ferreri, Christopher J., additional, Davis, James, additional, McGuirk, Joseph P., additional, Locke, Frederick L., additional, Baz, Rachid C., additional, Hamilton, Betty K., additional, Alsina, Melissa, additional, Sauter, Craig S., additional, Hashmi, Hamza, additional, and Patel, Krina, additional

Published
2022
Full Text
View/download PDF

50. Baseline Systemic Inflammatory Markers Interleukin 6 and Ferritin Are Associated with Toxicities and Progression-Free Survival in Multiple Myeloma Patients Treated with Idecabtagene Vicleucel

Author

Hansen, Doris K., primary, Peres, Lauren C., additional, Freeman, Ciara L., additional, Castaneda Puglianini, Omar Alexis, additional, Faramand, Rawan, additional, Oswald, Laura B., additional, Reid, Kayla M., additional, De Avila, Gabriel, additional, Blue, Brandon J., additional, Grajales-Cruz, Ariel F., additional, Ochoa, Jose, additional, Shrewsbury, Alexandria, additional, Powell, Cole T., additional, Copponex, Christina, additional, Kottra, Krista H., additional, Gonzalez, Rebecca, additional, Logue, Jennifer M., additional, Khimani, Farhad, additional, Elmariah, Hany, additional, Jain, Michael D., additional, Nishihori, Taiga, additional, Liu, Hien D., additional, Brayer, Jason, additional, Shain, Ken H., additional, Baz, Rachid, additional, Locke, Frederick L., additional, Alsina, Melissa, additional, and Davila, Marco L., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results